46047
EUROFARMA LABORATORIOS S/A
Sep 12, 2022
Brazil
Latin America and the Caribbean
Jun 24, 2022
B - Limited
Active
Oct 29, 2022
Regional Industry MAS LAC & EUR
other
Approved : Jun 24, 2022
Signed : Aug 30, 2022
Invested : Oct 25, 2022
other
The proposed investment entails an up to US$150 million A loan and an up to US$100 million B loan to Eurofarma Laboratórios S.A. (Eurofarma or the Company), a life science manufacturing company headquartered in Brazil with presence across Latin America. The proceeds will be used to fund i) the construction of a greenfield pharmaceutical manufacturing plant in Montes Claros, Brazil to produce oral solids and antibiotics; and (ii) the equipment needed to do the fill and finish of the Pfizer COVID-19 vaccine in Brazil (both investments together are defined as the “Project”).
Eurofarma was founded in Sao Paulo, southeast of Brazil, in 1972 as a family business and has grown rapidly to become a regional manufacturer of prescription drugs, generic drugs and medicine solutions to public and private hospitals.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Rua Brito Peixoto, 554
04582-020 - Brooklyn, São Paulo, SP